IN2013MU01225A - - Google Patents
Info
- Publication number
- IN2013MU01225A IN2013MU01225A IN1225MU2013A IN2013MU01225A IN 2013MU01225 A IN2013MU01225 A IN 2013MU01225A IN 1225MU2013 A IN1225MU2013 A IN 1225MU2013A IN 2013MU01225 A IN2013MU01225 A IN 2013MU01225A
- Authority
- IN
- India
- Prior art keywords
- compositions
- sitagliptin
- metformin
- salts
- present
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention provides solid oral pharmaceutical compositions comprising combination of metformin and sitagliptin or salts thereof. In particular, the present invention relates to a pharmaceutical composition comprising metformin and sitagliptin or salts thereof which is devoid of any glidant. The invention also includes process of preparing such compositions and method of use of such compositions for treating type II diabetes.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/766,939 US20150366863A1 (en) | 2013-03-28 | 2014-03-24 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
EP14722341.6A EP2996680A1 (en) | 2013-03-28 | 2014-03-24 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
IN1225MU2013 IN2013MU01225A (en) | 2013-03-28 | 2014-03-24 | |
PCT/IB2014/060081 WO2014170770A1 (en) | 2013-03-28 | 2014-03-24 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
ZA2015/05916A ZA201505916B (en) | 2013-03-28 | 2015-08-17 | Solid oral pharmaceutical compositions comprising fixed dose combination of metformin and sitagliptin or salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1225MU2013 IN2013MU01225A (en) | 2013-03-28 | 2014-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU01225A true IN2013MU01225A (en) | 2015-04-17 |
Family
ID=54395598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1225MU2013 IN2013MU01225A (en) | 2013-03-28 | 2014-03-24 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU01225A (en) |
-
2014
- 2014-03-24 IN IN1225MU2013 patent/IN2013MU01225A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021550792A1 (en) | 2-(morpholin-4-yl)-1,7-naphthyridines | |
PH12016501581A1 (en) | Benzimidazol-2-amines as midh1 inhibitors | |
PH12015500387A1 (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b | |
MX2015011229A (en) | Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b. | |
PH12016501807A1 (en) | Novel compounds | |
PH12017500533A1 (en) | 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
TW201613864A (en) | Novel compounds | |
BR112017005242A2 (en) | compound, pharmaceutical composition, and compound for use. | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
PH12016501814A1 (en) | Inhibitors of the wnt signalling pathways | |
MX2016009667A (en) | Crystal form a of compound a monobenzoate and preparation method thereof and pharmaceutical composition comprising same. | |
EA033769B9 (en) | Selected amide of -hydroxybutyric acid and uses thereof in the treatment of alcohol misuse | |
EA201491581A1 (en) | ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ | |
PH12017500323A1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
IN2013MU01225A (en) | ||
IN2013MU01223A (en) | ||
IN2013MU01224A (en) | ||
IN2013MU01222A (en) | ||
EA033077B1 (en) | Pharmaceutical composition containing 13 triglycerides, and preparations and use thereof | |
IN2014DN10683A (en) | ||
IN2013MU03427A (en) | ||
IN2013MU01158A (en) | ||
IN2013MU01159A (en) | ||
IN2014MU00184A (en) | ||
IN2014MU00185A (en) |